Annual Drug Patent Expirations for APTIOM
Aptiom is a drug marketed by Sunovion Pharms Inc and is included in one NDA. It is available from one supplier. There are eleven patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for APTIOM.
This drug has one hundred and fourteen patent family members in thirty-one countries.
The generic ingredient in APTIOM is eslicarbazepine acetate. One supplier is listed for this compound. Additional details are available on the eslicarbazepine acetate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
